Aerie Pharmaceuticals Inc.

(AERI) Trade

By |

Profile

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Contact Information

Website: www.aeriepharma.com
Email: ir@aeriepharma.com
Main Phone: +1 919 237-5300
Address: 4301 Emperor Boulevard
Address 2: Suite 400
State: NC
City / Town: Durham
Country: USA
Postal Code: 27703

Issuer Information

Exchange: NSD
CEO: Vicente Anido
Employees: 160
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 70.45 $ 3.10 (4.60%)
Last Price 70.45 Change $ 3.10 Change % 4.60 Tick N/A
Bid 57.65 Bid Size 200.00 Ask 71.00 Ask Size 20,000.00
Open 67.45 High 71.30 Low 65.70 Prev Close 67.35
Last Trade Volume 1.2 mi 52 Wk Hi 71.30 52 Wk Low 47.05
Market Cap 2.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,496,520.00 EPS (TTM) -4.39 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 29 46
Number of Buys 16 21
Number of Sells 13 25
Net Activity 34766 98763
Last 10 Buys Shares
Gerald D. Cagle 1,000
Gerald D. Cagle 1,000
Gerald D. Cagle 1,000
Gerald D. Cagle 1,000
Gerald D. Cagle 1,000
Richard J. Rubino 1,000
Vicente Anido 1,000
Thomas A. Mitro 1,000
Brian Levy 1,000
Last 10 Sell Shares
Vicente Anido 1,000
Vicente Anido 1,000
Vicente Anido 1,000
Vicente Anido 1,000
Casey C. Kopczynski 1,000
Casey C. Kopczynski 1,000
Vicente Anido 1,000
Vicente Anido 1,000
Casey C. Kopczynski 1,000
Geoffrey Duyk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 100 100 100 100
Low Target Price Estimate 70 70 70 70
Mean Target Price Estimate 81.56 81.56 81.56 81.56
Standard Deviation 8.47 8.47 8.47 8.47
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.3 1.3 1.3 1.3